Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Estradiol Downregulates MicroRNA-193a to Mediate Its Angiogenic Actions. | Cells | 2025 | 40801567 | PubTator, text mining | PubMed |
| Hereditary hemorrhagic telangiectasia in pediatrics: descriptive study in a specialized unit. | Arch Argent Pediatr | 2025 | 40762448 | PubTator, text mining | PubMed |
| A Rare Case of Intracranial Hemorrhage Mimicking a Neoplasm in a Child With Hereditary Hemorrhagic Telangiectasia. | Cureus | 2025 | 40761947 | PubTator, text mining | PubMed |
| Family planning, sexual activity and contraception in hereditary hemorrhagic telangiectasia: a European survey study. | Orphanet J Rare Dis | 2025 | 40751163 | PubTator, text mining | PubMed |
| Reviewing the Efficiency of the Initial Work-Up for Hereditary Hemorrhagic Telangiectasia in a Tertiary Referral University Center in Belgium. | Ear Nose Throat J | 2025 | 40741913 | PubTator, text mining | PubMed |
| Proteomics analysis reveals elevated RAB21 in serum-derived extracellular vesicles from patients with follicular thyroid carcinoma. | Oncol Lett | 2025 | 40740986 | PubTator, text mining | PubMed |
| A case report of 'Two-Hit' digenic mutations in PAH: role of PADN in management. | Front Pharmacol | 2025 | 40735484 | PubTator, text mining | PubMed |
| Hereditary hemorrhagic telangiectasia with pulmonary hypertension: a report of three cases. | J Thorac Dis | 2025 | 40688304 | PubTator, text mining | PubMed |
| Overlapping upstream ORFs ending at c.125 lead to reduced Endoglin, contributing to Hereditary Hemorrhagic Telangiectasia. | Commun Biol | 2025 | 40681766 | PubTator, text mining | PubMed |
| Coexistence of Hereditary Hemorrhagic Telangiectasia and Moyamoya Disease: A Case Report Highlighting a Potential Genetic Synergy. | Appl Clin Genet | 2025 | 40662163 | PubTator, text mining | PubMed |
| Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR Program. | Eur J Heart Fail | 2025 | 40660089 | PubTator, text mining | PubMed |
| The Role of Somatic Mutation in Hereditary Hemorrhagic Telangiectasia Pathogenesis. | J Clin Med | 2025 | 40648852 | PubTator, text mining | PubMed |
| Genotype-Phenotype Relationship in Hereditary Hemorrhagic Telangiectasia: Quality of Life and Cardiovascular Risk Evaluation. | J Clin Med | 2025 | 40648782 | PubTator, text mining | PubMed |
| The genetic epidemiology and genotype-phenotype correlations among Chinese children with idiopathic and heritable pulmonary arterial hypertension. | Respir Res | 2025 | 40604975 | PubTator, text mining | PubMed |
| Bone morphogenetic protein-9 controls pulmonary vascular growth and remodeling. | Proc Natl Acad Sci U S A | 2025 | 40549904 | PubTator, text mining | PubMed |
| Whole exome sequencing unravels genetic architecture and its clinical implications in pediatric pulmonary arterial hypertension. | Int J Cardiol | 2025 | 40516660 | PubTator, text mining | PubMed |
| Hemoptysis caused by hereditary hemorrhagic telangiectasia: A case report and literature review. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 40457800 | PubTator, text mining | PubMed |
| Integrative machine learning model for subtype identification and prognostic prediction in lung squamous cell carcinoma. | Discov Oncol | 2025 | 40410522 | PubTator, text mining | PubMed |
| Successful use of aflibercept for high cardiac output in hereditary hemorrhagic telangiectasia after failure of pazopanib and bevacizumab therapy. | J Thromb Haemost | 2025 | 40379104 | PubTator, text mining | PubMed |
| M2 Macrophage-Derived Extracellular Vesicles Reprogram Immature Neutrophils into Anxa1hi Neutrophils to Enhance Inflamed Bone Regeneration. | Adv Sci (Weinh) | 2025 | 40277454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=6